Tomio Kimura

This inventor holds 43 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Ube Industries, Inc., Sankyo Company, Limited, Daiichi Sankyo Company, Limited. Active years: 1984-2026.

USPTO Granted Patents = 43 (Patent Applications = 4)

% Patents Active = 81.4

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 10 (Patent Applications = 10)

Average Co-Inventor Count = 5.1

ph-index = 11

Forward Citations = 304(Granted Patents)

Location History:

Yamaguchi, JP (1984)
Niiza, JP (1997)
Ube, JP (1984 - 2000)
Shinagawa-ku, JP (2022)
Tokyo, JP (1999 - 2023)

Company Filing History:

Sankyo Company, Limited

patents

6 out of 460

Daiichi Sankyo Company, Limited

Sanwa Kagaku Kenkyusho Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1984-2026

Loading Chart...

Areas of Expertise:

Benzotriazole Derivative

Dihydropyrrolopyrazole

Substituted Guanidine

Protease Inhibitor

Heterocyclic Compound

Tumor Treatment

Aminoquinolone

Pyrrole Derivatives

4-Oxoquinoline

Cyclopenta[d]pyrimidine

Sulfonamide Derivatives

Quinoline Derivative

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12559504 - Benzotriazole derivative (2026-02-24),

2. 12304913 - Dihydropyrrolopyrazole derivative (2025-05-20),

3. 11814393 - Substituted guanidine compounds (2023-11-14),

4. 11465965 - Double-headed protease inhibitor (2022-10-11),

5. 11396514 - Substituted guanidine compounds (2022-07-26),

6. 10894798 - Substituted dihydropyrrolopyrazole derivative (2021-01-19),

7. 10759781 - Substituted guanidine derivatives (2020-09-01),

8. 10597375 - Halogen-substituted heterocyclic compound (2020-03-24),

9. 10273252 - Substituted dihydropyrrolopyrazole derivative (2019-04-30),

10. 10131679 - Substituted dihydropyrrolopyrazole compound (2018-11-20),

11. 10023554 - Halogen-substituted heterocyclic compound salt (2018-07-17),

12. 10000463 - Halogen-substituted heterocyclic compound (2018-06-19),

13. 9663463 - 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purpose (2017-05-30),

14. 8497397 - Substituted acrylamide derivative and pharmaceutical composition comprising the same (2013-07-30),

15. 8344029 - Substituted propanamide derivative and pharmaceutical composition containing the same (2013-01-01),

Title: The Innovative Mind of Tomio Kimura: A Journey Through Patents and Collaborations

Introduction: Tomio Kimura, an accomplished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceutical compounds. With an impressive portfolio of 41 patents, his work continues to impact the medical and scientific communities.

Latest Patents: Among his latest inventions are two notable patents that showcase his expertise. The first is a patent for substituted guanidine compounds, which provides a compound of general formula (I) and its pharmacologically acceptable salts, along with a pharmaceutical composition containing that compound. The second, a double-headed protease inhibitor, offers a highly safe and effective compound useful in preventing, alleviating, and treating various diseases involving enteropeptidase and trypsin inhibition. This invention also includes a method for producing the compound, demonstrating its potential for various therapeutic applications.

Career Highlights: Throughout his career, Tomio Kimura has collaborated with esteemed companies, including Ube Industries, Inc. and Sankyo Company, Limited. His work has consistently focused on developing innovative solutions to complex problems within the pharmaceutical industry.

Collaborations: Tomio has had the privilege of working alongside talented professionals, including Shigeru Ushiyama and Tetsushi Katsube. These collaborations have undoubtedly enriched his experience and contributed to the advancement of his groundbreaking inventions.

Conclusion: Tomio Kimura stands out as a remarkable inventor whose work has led to significant advancements in pharmaceutical applications. With an impressive number of patents and a history of collaboration with leading companies and experts, his contributions to science and medicine continue to inspire future innovations.